Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
about
Stereotactic Body Radiotherapy in the Management of Oligometastatic DiseaseStereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors.Feasibility and response of helical tomotherapy in patients with metastatic colorectal cancer.The radiosensitivity index predicts for overall survival in glioblastomaClinical results of mean GTV dose optimized robotic guided SBRT for liver metastasesIntegrating Biological Covariates into Gene Expression-Based Predictors of Radiation Sensitivity.Tumour radiosensitivity is associated with immune activation in solid tumours.The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity.Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.The role of Next-Generation Sequencing in tumoral radiosensitivity prediction.Role of stereotactic body radiation therapy for lung metastases from radio-resistant primary tumours.Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.Personalizing Radiation Treatment Delivery in the Management of Breast Cancer.Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis
P2860
Q28071733-4BC959FB-FD43-4463-B6B5-9DF46A6D6B1AQ33919725-BFDBA948-806B-475C-839D-5498D7A785D6Q36448079-1EA35B58-4685-474B-92F8-E8D148CF3A3EQ36544110-07EB53C4-EEAB-4EBB-AD1D-6850A50A1B84Q36945323-6B38388C-1B2A-4579-9B98-16AD9B6C8876Q38915814-832E7F64-F639-44D2-A301-4F4DBE4C7BC0Q40070538-D26500B0-904B-4026-862A-DF44A34319F6Q48229143-D0F67C64-BD16-4ECF-B61A-8122F701ED2EQ52591818-A883BA4C-A183-4E71-80A1-CB88C47EB263Q52805099-EA446FDB-E533-4544-8AA7-27BD35623529Q53748913-C5E20C05-5AAF-4316-A2D7-18D36989504BQ54966222-55C8F129-83F7-40F8-AFD1-917C51A27BA2Q55473791-AD28DE18-E5DE-4F14-9608-7A6FEC15E374Q57768371-D5FF84F5-4BB9-41C8-8663-91DB8C08E4E1
P2860
Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@ast
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@en
type
label
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@ast
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@en
prefLabel
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@ast
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@en
P2093
P2860
P1476
Differences Between Colon Canc ...... astatic SBRT Patient Selection
@en
P2093
Anders E Berglund
Kamran A Ahmed
Ravi Shridhar
Sarah E Hoffe
Steven A Eschrich
William J Fulp
P2860
P304
P356
10.1016/J.IJROBP.2015.01.036
P407
P577
2015-03-30T00:00:00Z